Skip to main content

Closed

ESLA: Estrella Immunopharma, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.15×avg

Market Cap

30.71MUSD

P/E Ratio

-2.1TTM

Div Yield

-ann

Estrella Immunopharma, Inc.

ESLANASDAQ Capital Market·USD·Closed

Estrella Immunopharma, Inc.

ESLANASDAQ·USD·Closed

$0.71

−0.89%

$0.71

−$0.01 (0.89%)

52W Range

1thpctl

Volume

0.15×avg

Mkt Cap

30.71MUSD

P/E

-2.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings